Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Primary membranous nephropathy (pMN) is a leading cause of nephrotic syndrome in adults. In most cases, this autoimmune kidney disease is associated with autoantibodies against the M-type phospholipase A2 receptor (PLA2R1) expressed on kidney podocytes, but the mechanisms leading to glomerular damage remain elusive. Here, we developed a cell culture model using human podocytes and found that anti-PLA2R1-positive pMN patient sera or isolated IgG4, but not IgG4-depleted sera, induced proteolysis of the 2 essential podocyte proteins synaptopodin and NEPH1 in the presence of complement, resulting in perturbations of the podocyte cytoskeleton. Specific blockade of the lectin pathway prevented degradation of synaptopodin and NEPH1. Anti-PLA2R1 IgG4 directly bound mannose-binding lectin in a glycosylation-dependent manner. In a cohort of pMN patients, we identified increased levels of galactose-deficient IgG4, which correlated with anti-PLA2R1 titers and podocyte damage induced by patient sera. Assembly of the terminal C5b-9 complement complex and activation of the complement receptors C3aR1 or C5aR1 were required to induce proteolysis of synaptopodin and NEPH1 by 2 distinct proteolytic pathways mediated by cysteine and aspartic proteinases, respectively. Together, these results demonstrated a mechanism by which aberrantly glycosylated IgG4 activated the lectin pathway and induced podocyte injury in primary membranous nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
Beck, L. H., Bonegio, R. G. B., Lambeau, G., Beck, D. M., Powell, D. W., Cummins, T. D., Klein, J. B., & Salant, D. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810457 · Cited by 2,347 · cited 2×
“In vivo, PLA2R1 is endogenously expressed at the surface of podocytes present in human glomeruli (4).”
BackgroundSelf-citationA Conditionally Immortalized Human Podocyte Cell Line Demonstrating Nephrin and Podocin Expression
Saleem, M. A., O’Hare, M. J., Reiser, J., Coward, R. J., Inward, C. D., Farren, T., Xing, C. Y., Ni, L., Mathieson, P. W., & Mundel, P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133630 · Cited by 1,120
Faul, C., Donnelly, M., Merscher-Gomez, S., Chang, Y. H., Franz, S., Delfgaauw, J., Chang, J.-M., Choi, H. Y., Campbell, K. N., Kim, K., et al. (2008) · Nature Medicine · doi:10.1038/nm.1857 · Cited by 991 · cited 3×
“Thus, blockade of the lecnism of proteinuria in several disease models (29), where protein kinase A–dependent phosphorylation protected synaptopodin and calcineurin-mediated dephosphorylation rendered it susceptible to cleavage.”
BackgroundMalhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B. (1995) · Nature Medicine · doi:10.1038/nm0395-237 · Cited by 786 · cited 3×
“In rheumatoid arthritis, galactose-deficient IgG glycoforms have been shown to directly bind MBL (17).”
BackgroundInfluentialPrimary Membranous Nephropathy
Couser, W. G. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11761116 · Cited by 690
Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review
Maverakis, E., Kim, K., Shimoda, M., Gershwin, M. E., Patel, F., Wilken, R., Raychaudhuri, S., Ruhaak, L. R., & Lebrilla, C. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.12.002 · Cited by 459 · cited 3×
“N-linked glycans attached to the conserved asparagine 297 of each CH2 domain of human IgG are important modulators of IgG effector functions (26).”
BackgroundProteinuria and Perinatal Lethality in Mice Lacking NEPH1, a Novel Protein with Homology to NEPHRIN
Donoviel, D. B., Freed, D. D., Vogel, H., Potter, D. G., Hawkins, E., Barrish, J. P., Mathur, B. N., Turner, C. A., Geske, R., Montgomery, C. A., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4829-4836.2001 · Cited by 442
Immunoglobulin G glycosylation in aging and diseases
Gudelj, I., Lauc, G., & Pezer, M. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.009 · Cited by 408 · cited 1×
“1172/JCI140453 and cancer, as well as in aging (26, 28, 35), affecting their proand antiinflammatory properties.”
BackgroundAge-related galactosylation of the N-linked oligosaccharides of human serum IgG.
Parekh, R., Roitt, I., Isenberg, D., Dwek, R., & Rademacher, T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1731 · Cited by 302 · cited 1×
“In line with previous observations (36), we also noticed a relevant effect of age.”
Synaptopodin regulates the actin-bundling activity of α-actinin in an isoform-specific manner
Asanuma, K., Kim, K., Oh, J., Giardino, L., Chabanis, S., Faul, C., Reiser, J., & Mundel, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23371 · Cited by 283
Doublier, S., Ruotsalainen, V., Salvidio, G., Lupia, E., Biancone, L., Conaldi, P. G., Reponen, P., Tryggvason, K., & Camussi, G. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64128-4 · Cited by 257 · cited 1×
“Alterations in the podocyte actin cytoskeleton and slit diaphragm–associated proteins have been documented in human and experimental membranous nephropathy (19, 20).”
BackgroundGlomerular Diseases: Membranous Nephropathy—A Modern View
Ponticelli, C. E., & Glassock, R. J. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04160413 · Cited by 243
Sever, S., Altintas, M. M., Nankoe, S. R., Möller, C. C., Ko, D., Wei, C., Henderson, J., del Re, E. C., Hsing, L., Erickson, A., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32022 · Cited by 226 · cited 1×
“Since dynamin is another proteolytic target of cathepsin L in podocytes (30), we assayed dynamin levels upon anti-PLA2R1– and complement-mediated damage in podocytes.”
BackgroundPodocyte Biology and Pathogenesis of Kidney Disease
Reiser, J., & Sever, S. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-163340 · Cited by 209 · cited 1×
“The actin cytoskeleton is critical in maintaining podocyte foot process integrity, and loss of actin stress fibers is associated with foot process effacement and proteinuria in vivo (44).”
BackgroundThe Role of Complement in Membranous Nephropathy
Ma, H., Sandor, D. G., & Beck, L. H. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.004 · Cited by 197 · cited 4×
“Although anti-PLA2R1 autoantibodies in pMN are primarily of the IgG4 subclass, which is generally considered not to bind and activate complement, other IgG subclasses are also present to a lesser extent (13).”
BackgroundInfluentialSelf-citation(2012) · Biopreservation and Biobanking · doi:10.1089/bio.2012.1022 · Cited by 171
Membranous nephropathy: from models to man
Beck, L. H., & Salant, D. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72270 · Cited by 169 · cited 2×
“Moreover, a variety of signaling events have been identified in in vitro models of antibody- and complement-mediated podocyte injury (5, 21, 22), but the mechanisms linking these pathways to slit diaphragm and cytoskeletal proteins remain elusive.”
BackgroundSelf-citationDNA damage is a novel response to sublytic complement C5b-9–induced injury in podocytes
Pippin, J. W., Durvasula, R. V., Petermann, A. T., Hiromura, K., Couser, W. G., & Shankland, S. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15645 · Cited by 156
Distribution of IgG subclasses in membranous nephropathy.
Doi, T., Mayumi, M., Kanatsu, K., Suehiro, F., & Hamashima, Y. (1984) · PubMed Central · Cited by 151
Experimental membranous nephropathy redux
Cybulsky, A. V., Quigg, R. J., & Salant, D. J. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00437.2004 · Cited by 140 · cited 4×
“Moreover, a variety of signaling events have been identified in in vitro models of antibody- and complement-mediated podocyte injury (5, 21, 22), but the mechanisms linking these pathways to slit diaphragm and cytoskeletal proteins remain elusive.”
BackgroundInfluentialSelf-citationJansen, B. C., Falck, D., de Haan, N., Ederveen, A. L. H., Razdorov, G., Lauc, G., & Wuhrer, M. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00171 · Cited by 135 · cited 1×
“LaCyTools, as described previously (53, 54).”
Self-citationMolecular Pathogenesis of Membranous Nephropathy
Ronco, P. M., & Dêbiec, H. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043811 · Cited by 135
Glomerular deposition of mannose-binding lectin in human glomerulonephritis
Lhotta, K., Würzner, R., & König, P. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.4.881 · Cited by 128 · cited 2×
“Previous data supporting the role of the lectin pathway in pMN include the observation of MBL deposition in membranous nephropathy biopsies (8, 15, 16) and the fact that C4 is generally present in the absence of C1q in glomerular immune complexes in pMN (8–10).”
BackgroundLi, K., Anderson, K. J., Peng, Q., Noble, A., Lu, B., Kelly, A. P., Wang, N., Sacks, S. H., & Zhou, W. (2008) · Blood · doi:10.1182/blood-2008-05-156646 · Cited by 123 · cited 1×
“Synaptopodin has been shown to be phosphorylated by protein kinase A (29), and C3aR1 and C5aR1 are G protein–coupled receptors that have been shown to inhibit cAMP production in dendritic cells (31, 32).”
BackgroundNephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy
Nakatsue, T., Koike, H., Han, G. D., Suzuki, K., Miyauchi, N., Yuan, H., Salant, D. J., Gejyo, F., Shimizu, F., & Kawachi, H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00328.x · Cited by 121 · cited 1×
“We did not find any effect on podocin, which has been reported to be affected in passive and active Heymann nephropathy (45).”
BackgroundSelf-citationDendritic cell function in allostimulation is modulated by C5aR signaling
Peng, Q., Li, K., Wang, N., Li, Q., Asgari, E., Lu, B., Woodruff, T. M., Sacks, S. H., & Zhou, W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804186 · Cited by 116 · cited 1×
“Synaptopodin has been shown to be phosphorylated by protein kinase A (29), and C3aR1 and C5aR1 are G protein–coupled receptors that have been shown to inhibit cAMP production in dendritic cells (31, 32).”
BackgroundPhospholipase A2 Receptor–Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency
Bally, S., Dêbiec, H., Ponard, D., Dijoud, F., Rendu, J., Fauré, J., Ronco, P. M., & Dumestre‐Pérard, C. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015101155 · Cited by 107 · cited 2×
“Nevertheless, MBL deficiency should dampen the level of lectin pathway activation, and in fact, the authors also reported an altered pattern of immunofluorescence staining (34), showing less C4d but stronger C3 deposition in the glomeruli of these MBL-deficient patients compared with other patients with pMN.”
BackgroundResultSweet but dangerous – the role of immunoglobulin G glycosylation in autoimmunity and inflammation
Biermann, M. H. C., Griffante, G., Podolska, M. J., Boeltz, S., Stürmer, J., Munoz, L. E., Bilyy, R. O., & i, M. H. (2016) · Lupus · doi:10.1177/0961203316640368 · Cited by 100 · cited 2×
“1172/JCI140453 and cancer, as well as in aging (26, 28, 35), affecting their proand antiinflammatory properties.”
BackgroundAnti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells
Quigg, R. J., Cybulsky, A. V., Jacobs, J. B., & Salant, D. J. (1988) · Kidney International · doi:10.1038/ki.1988.143 · Cited by 97
Self-citationHigh-Throughput Analysis of IgG Fc Glycopeptides by LC-MS
Falck, D., Jansen, B. C., de Haan, N., & Wuhrer, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6493-2_4 · Cited by 92 · cited 3×
“LaCyTools, as described previously (53, 54).”
Self-citationMeyer‐Schwesinger, C., Tomas, N. M., Dehde, S., Seifert, L., Hermans‐Borgmeyer, I., Wiech, T., Koch‐Nolte, F., Huber, T. B., & Zahner, G. (2019) · Kidney International · doi:10.1016/j.kint.2019.10.022 · Cited by 90 · cited 1×
“Even a recently reported mouse model based on transgenic expression of PLA2R1 in podocytes (7) did not recapitulate the human disease because of the differences between rodent and human IgG subclasses and their capabilities to bind complement.”
BackgroundOECD guidelines on human biobanks and genetic research databases.
(2010) · PubMed · Cited by 90
Immunohistopathologic Evaluation of C1q in 800 Renal Biopsy Specimens
Jennette, J. C., & Hipp, C. G. (1985) · American Journal of Clinical Pathology · doi:10.1093/ajcp/83.4.415 · Cited by 88
Proteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach
Yu, S. M.-W., Nissaisorakarn, P., Husain, I., & Jim, B. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00221 · Cited by 87 · cited 1×
“Proteinuric kidney diseases, including membranous nephropathy, are characterized by the loss of these foot processes (foot process effacement) through perturbations of slit diaphragm proteins, such as nephrin, podocin, and NEPH1, and proteins that regulate cytoskeletal structure and dynamics, including synaptopodin, a…”
BackgroundHéja, D., Harmat, V., Fodor, K., Wilmanns, M., Dobó, J., Kékesi, K. A., Závodszky, P., Gál, P., & Pál, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354332 · Cited by 84 · cited 5×
“We observed that adding recombinant MBL increased complement-mediated damage of the podocytes, while specific inhibition of the key lectin pathway activators MASP-1 and -2 by the small protein inhibitors SGMI-1 and SGMI-2 (12) blocked complement activation and protected podocytes from synaptopodin and NEPH1 degradatio…”
BackgroundMethodInfluentialSelf-citationGlomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy
Hayashi, N., Okada, K., Matsui, Y., Fujimoto, K., Adachi, H., Yamaya, H., Matsushita, M., & Yokoyama, H. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx235 · Cited by 82 · cited 2×
“Previous data supporting the role of the lectin pathway in pMN include the observation of MBL deposition in membranous nephropathy biopsies (8, 15, 16) and the fact that C4 is generally present in the absence of C1q in glomerular immune complexes in pMN (8–10).”
BackgroundComplement-Mediated Cellular Injury
Takano, T., Elimam, H., & Cybulsky, A. V. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.009 · Cited by 80 · cited 1×
“Several cellular mechanisms of sublytic complement– induced podocyte damage have been described for rodent podocytes and non-IgG4 antibodies directed against antigens other than PLA2R1 (21, 40).”
BackgroundC3a receptor blockade protects podocytes from injury in diabetic nephropathy
Morigi, M., Perico, L., Corna, D., Locatelli, M., Cassis, P., Carminati, C. E., Bolognini, S., Zoja, C., Remuzzi, G., Benigni, A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.131849 · Cited by 77 · cited 1×
“Increased C3aR1 expression has also been recently reported in rodent models of diabetic nephropathy (37), suggesting that our observation might not be specific to pMN.”
BackgroundSaran, A. M., Yuan, H., Takeuchi, E., McLaughlin, M. M., & Salant, D. J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00305.x · Cited by 77 · cited 1×
“Alterations in the podocyte actin cytoskeleton and slit diaphragm–associated proteins have been documented in human and experimental membranous nephropathy (19, 20).”
BackgroundSelf-citationChang, W., White, M. R., Moyo, P., McClear, S., Thiel, S., Hartshorn, K. L., & Takahashi, K. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-64 · Cited by 75 · cited 1×
“Recombinant human MBL (rh-MBL, gift of Kazue Takahashi) (56) was added (2 μg/mL, 50 μL per well) to some wells with or without mannose (100 or 500 mM).”
MethodNing, L., Suleiman, H. Y., & Miner, J. H. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050572 · Cited by 75
Kistler, A. D., Singh, G., Altintas, M. M., Yu, H., Fernandez, I. C., Gu, C., Wilson, C., Srivastava, S. K., Dietrich, A., Walz, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.488122 · Cited by 73 · cited 1×
“Moreover, a variety of signaling events have been identified in in vitro models of antibody- and complement-mediated podocyte injury (5, 21, 22), but the mechanisms linking these pathways to slit diaphragm and cytoskeletal proteins remain elusive.”
BackgroundSelf-citationBorza, D. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00157 · Cited by 63 · cited 1×
“Remarkably, the immune deposits in pMN contain substantial amounts of complement, including C3 and C5 cleavage products and the terminal C5b-9 complex, yet the predominant IgG subclass in pMN is IgG4, which is incapable of activating complement via the classical pathway (6).”
BackgroundYang, Y., Wang, C., Jin, L., He, F.-G., Li, C., Gao, Q., Chen, G., He, Z., Song, M., Zhou, Z., et al. (2016) · Immunologic Research · doi:10.1007/s12026-016-8790-1 · Cited by 60 · cited 1×
“In support of this hypothesis, deglycosylation of IgG4 protected synaptopodin and NEPH1 in the cellular assay, abrogated MBL and complement fixFurther supporting the role of the lectin pathway in antiPLA2R1–associated pMN, MBL and MASP-1 serum levels were previously observed to be higher in PLA2R1-positive versus PLA2…”
ResultMembranous nephropathy: thinking through the therapeutic options
Cattran, D., & Brenchley, P. E. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw404 · Cited by 58 · cited 1×
“Current treatments for pMN consist of initial nonimmunosuppressive therapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and immunosuppressive treatments in the case of severe disease or persistent nephrotic syndrome despite conservative treatment (46).”
Scherer, H. U., Wang, J., Toes, R. E. M., van der Woude, D., Koeleman, C. A. M., de Boer, A. R., Huizinga, T. W. J., Deelder, A. M., & Wuhrer, M. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800098 · Cited by 41 · cited 1×
“To determine the glycosylation pattern of PLA2R1-specific IgG4, antigen-specific IgG4 was isolated using the EUROIMMUN antiPLA2R1 ELISA as described earlier (55).”
MethodSelf-citationPodocyte injury elicits loss and recovery of cellular forces
Haley, K. E., Kronenberg, N. M., Liehm, P., Elshani, M., Bell, C., Harrison, D. J., Gather, M. C., & Reynolds, P. A. (2018) · Science Advances · doi:10.1126/sciadv.aap8030 · Cited by 36
Medjeral‐Thomas, N., & O'Shaughnessy, M. M. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.12.004 · Cited by 32 · cited 1×
“Furthermore, MBL is found in biopsies of IgAN patients, and in addition to inducing anti-IgA1 autoantibodies, galactose-deficient IgA1 in IgAN might bind MBL and other lectins, similar to what we have observed for IgG4 in pMN (48).”
ResultThe actin cytoskeleton facilitates complement-mediated activation of cytosolic phospholipase A2
Cybulsky, A. V., Takano, T., Papillon, J., Khadir, A., Bijian, K., & Berre, L. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00260.2003 · Cited by 23
Cited by
A guide to complement biology, pathology and therapeutic opportunity
Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00926-1 · Cited by 320
The Unique Properties of IgG4 and Its Roles in Health and Disease
Rispens, T., & Huijbers, M. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00871-z · Cited by 282
Metadata
- Authors
- Haddad, G., Lorenzen, J. M., Ma, H., de Haan, N., Seeger, H., Zaghrini, C., Brandt, S., Kölling, M., Wegmann, U., Kiss, B., Pál, G., Gál, P., Wüthrich, R. P., Wuhrer, M., Beck, L. H., Salant, D. J., Lambeau, G., & Kistler, A. D.
- Venue
- Journal of Clinical Investigation
- Published
- 2021-03-01
- Volume
- 131
- Issue
- 5
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W3115713292
- Cited by
- 177
- References
- 49
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.